World's First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study.
Tjun Yip TangCharyl Jia Qi YapShereen Xue Yun SoonSze Ling ChanQingWei Shaun LeeHao Yun YapHsien Ts'ung Luke TayTze Tec ChongPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2021)
Selution SLR drug-eluting balloon is a safe and efficacious modality in treating complex tibial arterial occlusive lesions in what is an otherwise frail cohort of CLTI patients, with a high prevalence of diabetes and end-stage renal failure. Technical and clinical success rates are high and 6-month target lesion patency and AFS are more than satisfactory.